Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of suvorexant, added to existing
medications, for treatment-resistant insomnia in individuals with bipolar disorder. The
investigators hypothesize that participants receiving suvorexant for one week will experience
significantly greater improvement in sleep duration compared to participants receiving
placebo.